Stay updated on Pembrolizumab for Lung Cancer Prevention Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Lung Cancer Prevention Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T15:51:27.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T09:31:04.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    0.9%
    Check dated 2025-05-30T04:27:34.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone a revision, updating the version number from v2.15.2 to v2.16.0, but it has removed all previously listed content related to the IMPRINT-Lung study and AJCC staging for lung cancer.
    Difference
    5%
    Check dated 2025-05-22T22:07:20.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:20:43.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the removal of detailed information about a phase II trial studying pembrolizumab for lung cancer prevention, while adding new classifications for lung cancer stages and registry identifiers.
    Difference
    61%
    Check dated 2025-04-16T20:35:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Lung Cancer Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.